Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 169

Similar articles for PubMed (Select 23100560)

1.

Interleukin-1 promotes coagulation, which is necessary for protective immunity in the lung against Streptococcus pneumoniae infection.

Yang H, Ko HJ, Yang JY, Kim JJ, Seo SU, Park SG, Choi SS, Seong JK, Kweon MN.

J Infect Dis. 2013 Jan 1;207(1):50-60. doi: 10.1093/infdis/jis651. Epub 2012 Oct 24.

2.

Essential role for the p40 subunit of interleukin-12 in neutrophil-mediated early host defense against pulmonary infection with Streptococcus pneumoniae: involvement of interferon-gamma.

Yamamoto N, Kawakami K, Kinjo Y, Miyagi K, Kinjo T, Uezu K, Nakasone C, Nakamatsu M, Saito A.

Microbes Infect. 2004 Nov;6(14):1241-9.

PMID:
15555529
4.

Contribution of IL-1 to resistance to Streptococcus pneumoniae infection.

Kafka D, Ling E, Feldman G, Benharroch D, Voronov E, Givon-Lavi N, Iwakura Y, Dagan R, Apte RN, Mizrachi-Nebenzahl Y.

Int Immunol. 2008 Sep;20(9):1139-46. doi: 10.1093/intimm/dxn071. Epub 2008 Jul 1.

5.

Mucosal administration of flagellin protects mice from Streptococcus pneumoniae lung infection.

Muñoz N, Van Maele L, Marqués JM, Rial A, Sirard JC, Chabalgoity JA.

Infect Immun. 2010 Oct;78(10):4226-33. doi: 10.1128/IAI.00224-10. Epub 2010 Jul 19.

6.

IL-10 is an important mediator of the enhanced susceptibility to pneumococcal pneumonia after influenza infection.

van der Sluijs KF, van Elden LJ, Nijhuis M, Schuurman R, Pater JM, Florquin S, Goldman M, Jansen HM, Lutter R, van der Poll T.

J Immunol. 2004 Jun 15;172(12):7603-9.

7.

Interleukin-6 gene-deficient mice show impaired defense against pneumococcal pneumonia.

van der Poll T, Keogh CV, Guirao X, Buurman WA, Kopf M, Lowry SF.

J Infect Dis. 1997 Aug;176(2):439-44.

8.

Role of interferon-gamma in Valpha14+ natural killer T cell-mediated host defense against Streptococcus pneumoniae infection in murine lungs.

Nakamatsu M, Yamamoto N, Hatta M, Nakasone C, Kinjo T, Miyagi K, Uezu K, Nakamura K, Nakayama T, Taniguchi M, Iwakura Y, Kaku M, Fujita J, Kawakami K.

Microbes Infect. 2007 Mar;9(3):364-74. Epub 2007 Jan 9.

PMID:
17314060
9.

Interleukin-1 receptor antagonist transiently impairs antibacterial defense but not survival in murine pneumococcal pneumonia.

Rijneveld AW, Florquin S, Speelman P, Edwards CK, Dinarello CA, van der Poll T.

Eur Cytokine Netw. 2003 Oct-Dec;14(4):242-5.

PMID:
14715417
10.

IL-1 receptor type 1 gene-deficient mice demonstrate an impaired host defense against pneumococcal meningitis.

Zwijnenburg PJ, van der Poll T, Florquin S, Roord JJ, Van Furth AM.

J Immunol. 2003 May 1;170(9):4724-30.

11.

TNF-alpha compensates for the impaired host defense of IL-1 type I receptor-deficient mice during pneumococcal pneumonia.

Rijneveld AW, Florquin S, Branger J, Speelman P, Van Deventer SJ, van der Poll T.

J Immunol. 2001 Nov 1;167(9):5240-6.

12.

Interleukin 1 receptor-associated kinase m impairs host defense during pneumococcal pneumonia.

van der Windt GJ, Blok DC, Hoogerwerf JJ, Lammers AJ, de Vos AF, Van't Veer C, Florquin S, Kobayashi KS, Flavell RA, van der Poll T.

J Infect Dis. 2012 Jun 15;205(12):1849-57. doi: 10.1093/infdis/jis290. Epub 2012 Apr 5.

14.

Involvement of the platelet-activating factor receptor in host defense against Streptococcus pneumoniae during postinfluenza pneumonia.

van der Sluijs KF, van Elden LJ, Nijhuis M, Schuurman R, Florquin S, Shimizu T, Ishii S, Jansen HM, Lutter R, van der Poll T.

Am J Physiol Lung Cell Mol Physiol. 2006 Jan;290(1):L194-9. Epub 2005 Aug 12.

15.

Importance of CXC chemokine receptor 2 in alveolar neutrophil and exudate macrophage recruitment in response to pneumococcal lung infection.

Herbold W, Maus R, Hahn I, Ding N, Srivastava M, Christman JW, Mack M, Reutershan J, Briles DE, Paton JC, Winter C, Welte T, Maus UA.

Infect Immun. 2010 Jun;78(6):2620-30. doi: 10.1128/IAI.01169-09. Epub 2010 Apr 5.

16.

The integrins Mac-1 and alpha4beta1 perform crucial roles in neutrophil and T cell recruitment to lungs during Streptococcus pneumoniae infection.

Kadioglu A, De Filippo K, Bangert M, Fernandes VE, Richards L, Jones K, Andrew PW, Hogg N.

J Immunol. 2011 May 15;186(10):5907-15. doi: 10.4049/jimmunol.1001533. Epub 2011 Apr 1.

17.

Innate immune defense against pneumococcal pneumonia requires pulmonary complement component C3.

Kerr AR, Paterson GK, Riboldi-Tunnicliffe A, Mitchell TJ.

Infect Immun. 2005 Jul;73(7):4245-52.

18.

Recombinant activated protein C attenuates coagulopathy and inflammation when administered early in murine pneumococcal pneumonia.

Schouten M, van 't Veer C, Roelofs JJ, Gerlitz B, Grinnell BW, Levi M, van der Poll T.

Thromb Haemost. 2011 Dec;106(6):1189-96. doi: 10.1160/TH11-06-0438. Epub 2011 Sep 8.

PMID:
21901240
19.

Single immunoglobulin interleukin-1 receptor-related molecule impairs host defense during pneumonia and sepsis caused by Streptococcus pneumoniae.

Blok DC, van Lieshout MH, Hoogendijk AJ, Florquin S, de Boer OJ, Garlanda C, Mantovani A, van't Veer C, de Vos AF, van der Poll T.

J Innate Immun. 2014;6(4):542-52. doi: 10.1159/000358239. Epub 2014 Feb 14.

PMID:
24556793
20.

Decreased alveolar macrophage apoptosis is associated with increased pulmonary inflammation in a murine model of pneumococcal pneumonia.

Marriott HM, Hellewell PG, Cross SS, Ince PG, Whyte MK, Dockrell DH.

J Immunol. 2006 Nov 1;177(9):6480-8.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk